Potential and challenges of using stimuli-responsive, biomaterials-based nanomedicines in treating glioblastoma (IMAGE)
Caption
Blood–brain barrier (BBB) prevents the vast majority of drugs from reaching glioblastoma tumor tissue at therapeutic concentrations. To overcome this effect, recent research has been focusing on nanomaterial-based drug delivery to increase treatment efficacy. A new review study has explored the potential and limitations of BBB‑aware, stimuli‑responsive, and biomimetic nanomedicines for glioblastoma
Credit
Argonne National Laboratory for Flickr Image source link: https://openverse.org/image/83dae2b9-a21e-4521-8bab-f139b261b510?q=nanoparticle&p=59
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. Adaptations must be shared under the same terms.
License
CC BY-NC-SA